Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.49 |
| ▸ | PARK7 | Q99497 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25756589 | 0.80 | CYP1B1 (0.46) | CYP1B1PARK7MAPTTP53ALDH1A1 | |
| SCHEMBL17165873 | 0.76 | PARK7 (0.44) | CYP1B1PARK7MAPTTP53ACHE | |
| SCHEMBL19630025 | 0.75 | PARK7 (0.50) | CYP1B1PARK7MAPTTP53ACHE | |
| SCHEMBL7243578 | 0.75 | CTRB1 (0.49) | CYP1B1PARK7MAPTTP53ACHE | |
| SCHEMBL7244266 | 0.73 | PARK7 (0.50) | PARK7MAPTTP53ACHEALDH1A1 | |
| SCHEMBL28026697 | 0.71 | PARK7 (0.53) | CYP1B1PARK7MAPTACHEALDH1A1 | |
| SCHEMBL31003772 | 0.71 | PARK7 (0.53) | CYP1B1PARK7MAPTALDH1A1HTT | |
| SCHEMBL17165976 | 0.71 | DRD2 (0.35) | CYP1B1PARK7TP53ALDH1A1HTT | |
| SCHEMBL31528311 | 0.69 | CHRM5 (0.42) | CYP1B1PARK7MAPTTP53ALDH1A1 | |
| SCHEMBL22667286 | 0.68 | CUL4A (0.68) | PARK7MAPTACHEALDH1A1CUL4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10385065-B2 | Antibacterial compounds | REDX PHARMA PLC (GB) | 2019-08-20 | — | — | US | disclosed |
| US-10385065-B2 | Antibacterial compounds | REDX PHARMA PLC (GB) | 2019-08-20 | — | — | US | disclosed |
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-06-08 | — | — | US | disclosed |
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-06-08 | — | — | US | disclosed |
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-06-08 | — | — | US | disclosed |
| WO-2017046603-A1 | ANTIBACTERIAL COMPOUNDS AND NEW USES THEREOF | REDX PHARMA PLC (GB) | 2017-03-23 | — | — | WO | disclosed |
| EP-3129386-A1 | ANTIBACTERIAL COMPOUNDS | Redx Pharma PLC (GB) | 2017-02-15 | — | — | EP | disclosed |
| WO-2015155549-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2015-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158708-A1 | ANTIBACTERIAL COMPOUNDS | ABCC1, SLC11A2, NQO2 | CYP1B1 1046/4885PARK7 2131/4885MAPT 2265/4885 |
| US-10385065-B2 | Antibacterial compounds | ABCC1, SLC11A2, NQO2 | CYP1B1 1046/4885PARK7 2131/4885MAPT 2265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.